

Austedo can be hard to find due to specialty pharmacy rules, prior auth delays, high costs, and niche demand. Learn why and what you can do about it.
If you or someone you love has been prescribed Austedo (deutetrabenazine), you may have already discovered something frustrating: getting it in your hands isn't always easy. You're not alone. Many patients across the country report difficulty filling their Austedo prescription, even when their doctor has already written the script.
In this article, we'll break down exactly why Austedo is so hard to find in 2026, what's behind the access issues, and — most importantly — what you can do about it.
Austedo is a prescription medication made by Teva Pharmaceuticals. It belongs to a class of drugs called VMAT2 inhibitors (vesicular monoamine transporter 2 inhibitors). It works by reducing the amount of certain brain chemicals — like dopamine — that can cause involuntary movements.
Austedo is FDA-approved to treat two conditions:
Austedo is available as immediate-release tablets (taken twice daily with food) and as Austedo XR (extended-release tablets taken once daily). There is no generic version available as of 2026.
Unlike common medications you can pick up at any corner pharmacy, Austedo is typically distributed through specialty pharmacies. These are pharmacies that handle complex, high-cost medications requiring special storage, handling, or patient monitoring.
This means your local CVS, Walgreens, or independent pharmacy may not stock Austedo at all. Even if they can technically order it, many choose not to because of the cost and low demand. You may need to use a specific mail-order or specialty pharmacy designated by your insurance plan.
This adds time to the process. Instead of walking in and picking up your medication the same day, you might wait days or even weeks for delivery — especially if it's your first fill.
Most insurance plans require prior authorization (PA) before they'll cover Austedo. This means your doctor has to submit paperwork to your insurance company proving that Austedo is medically necessary for your condition.
Prior authorization can take anywhere from a few days to several weeks, depending on your insurer. If the initial request is denied, your doctor may need to file an appeal, which adds even more time. During this waiting period, you can't fill your prescription.
Some insurers also require step therapy, meaning you may have to try (and fail on) a less expensive medication before they'll approve Austedo. This can delay access by months.
Austedo costs between $7,000 and $10,000 per month without insurance. That's not a typo. At that price point, most retail pharmacies simply can't afford to keep it on the shelf. Stocking even a single bottle ties up thousands of dollars in inventory for a medication that may only have one or two local patients.
This economic reality means pharmacies are reluctant to order Austedo unless they have a confirmed, paid prescription in hand. The result? Even more delays for patients.
If you're concerned about the cost of Austedo, check out our guide on how to save money on Austedo in 2026.
Tardive dyskinesia and Huntington's chorea are relatively uncommon conditions compared to, say, high blood pressure or diabetes. The total number of patients who need VMAT2 inhibitors is small, which means:
There are only two other VMAT2 inhibitors on the market — Ingrezza (valbenazine) and Xenazine (tetrabenazine) — and they face similar access challenges. If you're exploring options, read our article on alternatives to Austedo.
The good news is there are concrete steps you can take to improve your chances of getting Austedo without unnecessary delays.
Medfinder helps you search for pharmacies that currently have Austedo in stock near you. Instead of calling pharmacy after pharmacy, you can check availability online and save yourself hours of frustration.
Ask your doctor or insurance company which specialty pharmacies are in your plan's network. Getting set up with the right specialty pharmacy from the start can prevent delays down the road. Many specialty pharmacies also offer delivery directly to your home.
Talk to your doctor's office about submitting the prior authorization request as early as possible — ideally before your current supply runs out. Ask them to include all supporting documentation upfront to reduce the chance of a denial or request for more information.
Teva Pharmaceuticals, the maker of Austedo, has a patient support program that can help with insurance issues, copay assistance, and finding a pharmacy. Visit austedo.com or call their support line for help navigating access barriers.
If you're having trouble finding immediate-release Austedo, ask your doctor about Austedo XR, the once-daily extended-release version. It may be available through different distribution channels or have better availability at certain pharmacies.
For more detailed tips, see our full guide on how to find Austedo in stock near you.
Austedo is a valuable medication for people living with tardive dyskinesia and Huntington's chorea, but getting it can feel like an uphill battle. The combination of specialty pharmacy distribution, prior authorization requirements, sky-high costs, and niche market demand creates a perfect storm of access challenges.
But you don't have to navigate this alone. Tools like Medfinder can help you locate Austedo in stock, and programs from Teva can help reduce costs. Stay proactive, work closely with your doctor, and don't hesitate to ask for help.
For the latest on Austedo availability, visit our Austedo shortage update for 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.